Malte Peters

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Julie Fogarty, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Malte Peters:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. President & CEO, Director Common Stock 367,500 $3,256,050 $8.86 08 Jan 2026 Direct
HOOKIPA Pharma Inc. Chief Executive Officer, Director Common Stock 54,347 $44,656 $0.8217 19 Aug 2025 Direct
Tango Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 1,650,000 08 Jan 2026 Direct

Insider Reports Filed by Malte Peters

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 08 Jan 2026 2 $0 4 President & CEO, Director 12 Jan 2026, 06:15
TNGX Tango Therapeutics, Inc. 03 Nov 2025 1 $0 4 Director 04 Nov 2025, 09:25
HOOK HOOKIPA Pharma Inc. 19 Aug 2025 1 -$20,684 4 Chief Executive Officer, Director 09 Oct 2025, 16:22
HOOK HOOKIPA Pharma Inc. 22 Jul 2025 1 -$26,842 4 Chief Executive Officer, Director 23 Jul 2025, 18:09
TNGX Tango Therapeutics, Inc. 05 Jun 2025 2 $0 4 Director 09 Jun 2025, 17:51
HOOK HOOKIPA Pharma Inc. 22 Jul 2024 1 $0 4 Chief Executive Officer, Director 24 Jul 2024, 16:17
HOOK HOOKIPA Pharma Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:15
TNGX Tango Therapeutics, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 17:21
HOOK HOOKIPA Pharma Inc. 09 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:16
TNGX Tango Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 21:33
HOOK HOOKIPA Pharma Inc. 01 Jan 2023 0 $0 3 Director 18 Apr 2023, 19:42
TNGX Tango Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:29
TNGX Tango Therapeutics, Inc. 10 Aug 2021 0 $0 3 Director 12 Aug 2021, 20:37